CN110496148A - A kind of eucommia ulmoides extracts composition that treating the hypertension of pregnancy and its application - Google Patents

A kind of eucommia ulmoides extracts composition that treating the hypertension of pregnancy and its application Download PDF

Info

Publication number
CN110496148A
CN110496148A CN201910896111.8A CN201910896111A CN110496148A CN 110496148 A CN110496148 A CN 110496148A CN 201910896111 A CN201910896111 A CN 201910896111A CN 110496148 A CN110496148 A CN 110496148A
Authority
CN
China
Prior art keywords
pregnancy
eucommia ulmoides
parts
ulmoides extracts
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910896111.8A
Other languages
Chinese (zh)
Other versions
CN110496148B (en
Inventor
陈梁
李小锋
刘厚权
夏淑英
胡吉忠
张俊英
张金良
周朝忠
毛金娣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGXI PUZHENG PHARMACEUTICAL CO Ltd
Original Assignee
JIANGXI PUZHENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGXI PUZHENG PHARMACEUTICAL CO Ltd filed Critical JIANGXI PUZHENG PHARMACEUTICAL CO Ltd
Priority to CN201910896111.8A priority Critical patent/CN110496148B/en
Publication of CN110496148A publication Critical patent/CN110496148A/en
Application granted granted Critical
Publication of CN110496148B publication Critical patent/CN110496148B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/35Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to Chinese medical extract fields, and in particular to a kind of eucommia ulmoides extracts composition for treating the hypertension of pregnancy and its application.The composition includes: 30-50 parts of 20-60 parts of mixed extract, the general flavone of 20-40 parts of ursolic acid, 10-25 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside.By enzymatic hydrolysis, step by step arithmetic, dissolution and etc. be made, preparation method is simple and efficient, and manufactured eucommia ulmoides extracts composition has preferable effect in terms of the treatment of the treatment hypertension of pregnancy, while reducing its side effect.

Description

A kind of eucommia ulmoides extracts composition that treating the hypertension of pregnancy and its application
Technical field
The invention belongs to Chinese medical extract fields, and in particular to a kind of eucommia ulmoides extracts composition for treating the hypertension of pregnancy And its application.
Background technique
Gestation hypertension refers to that women gestation the symptoms such as hypertension, oedema, albuminuria occurs after 20 weeks, in transient, It disappears after childbirth.One of the main reason for belonging to the peculiar disease of gestation, being current pregnant and lying-in women, peri-natal infant illness and death.In gestation For later period systolic pressure more than 140 millimetress of mercury (18.7 kPas), diastolic pressure is more than 90 millimetress of mercury (12.0 kPas), it is necessary to examine Consider hypertension.The reason of hypertension of pregnancy, there are many theories, it is considered that and it is that certain substance from placenta enters maternal blood, Cause the immune factor of pregnant woman's body to change, lead to the whole body arteriolar spasm of pregnant woman and hypertension occurs, also studies have found that It is related with inherent cause.Main clinical manifestation are as follows:
Hypertension: blood pressure reaches 140/90 millimetres of mercury twice, can make diagnosis.Albuminuria: midstream urine should be taken to carry out It checks, it is abnormal that all twenty-four-hour urine protein quantifications, which are greater than 0.5 gram,.There is hypertension simultaneously and Urine proteins are preeclampsia.Oedema. Subjective symptoms: there are the symptoms such as no headache, dim eyesight, uncomfortable in chest, nauseous and vomiting.The appearance of these subjective symptoms indicates progression of the disease Stage preeclampsia is entered, corresponding check and processing should be done in time.Twitch and stupor: twitch and stupor are that this disease develops to sternly Weight the stage performance, should medical treatment immediately processing, in due course terminal pregnancy.
The danger that the women of the hypertension of pregnancy or pre-eclampsia suffers from hypertension in the later years will increase, or even always The probability that it is hospitalized by hypertension related disorders after by 50 years is still very high, and the danger of women's apoplexy of history of pre-eclampsia is 4 times of blood pressure in pregnancy normal women.
Again since antihypertensive drugs can enter fetus by placenta or appear in milk, it is secondary that poison is generated to fetus or baby Effect.Therefore Chinese medicine is clinically mostly used, but some Chinese Patent Medicines also contain the unfavorable western medicine composition of a certain amount of pair of fetus in fact, it is pregnant Woman will also be paid close attention to using Chinese patent drug and Chinese herbal medicine decompression.
102670791 A of Chinese patent application CN discloses a kind of alleviation hypertension Cortex Eucommiae traditional Chinese medicine oral liquid, is by following Made of the bulk pharmaceutical chemicals of parts by weight: 150-300 parts of Cortex Eucommiae, 150-300 parts of Radix Angelicae Sinensis, 150-300 parts of Morinda officinalis, fleece-flower root 150- 300 parts, 150-300 parts of lotus leaf, the oral solution can release rapidly the tinnitus of caused by hypertension, dizzy, headache, shortness of breath and palpitation, mistake The symptoms such as sleep do not isolate and purify process to effective component but since component is numerous, impurity in traditional Chinese medicinal components and it is harmful at Dividing effectively to exclude.
103750156 A of Chinese patent application CN disclose it is a kind of using folium cortex eucommiae, low cost, rich in Geniposidic acid, Aucubin isoreactivity substance is also enriched in the nutriments such as amino acid, glucose, and can reduce the vermicelli processing side of gutta-percha Method, can apply to prevention and diet in, but its treatment the hypertension of pregnancy effect in terms of it still needs further improvement.
Summary of the invention
To overcome the above technical problem, the present invention provides a kind of eucommia ulmoides extracts composition for treating the hypertension of pregnancy, The composition can effectively treat the hypertension of pregnancy, and preparation method is simple and efficient, and can effectively improve the purity of effective component, reduce Impurity content reduces side effect.
In order to achieve the above object, technical solution provided by the invention is as follows:
A kind of eucommia ulmoides extracts composition for treating the hypertension of pregnancy, in parts by weight, the composition includes: bear 20-40 parts of tartaric acid, 10-25 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside mixed extract 20- 60 parts, 30-50 parts of general flavone.
Preferably, in parts by weight, the composition includes: 25-30 parts of ursolic acid, 15-20 parts of chlorogenic acid, rosin 35-45 parts of 30-50 parts of mixed extract, the general flavone of alcohol diglucoside and syringaresinol diglucoside.
Another object of the present invention is to provide the preparation sides of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy Method, comprising the following steps:
(1) it takes Cortex Eucommiae to crush, is added to the water, digest, filtering obtains enzymolysis liquid and filter residue 1;
(2) filter residue 1 is taken, after petroleum ether, is placed in cold ethyl alcohol, ultrasound, filtering obtains alcoholic solution 1, to alcoholic solution 1 Middle addition water, the solid of precipitation are ursolic acid;
(3) enzymolysis liquid is successively adsorbed through XDA-1 type macroreticular resin, S-8 type macroporous absorbent resin;XDA-1 after absorption Type macroreticular resin is concentrated through ethanol elution, dry, obtains chlorogenic acid;
S-8 type macroporous absorbent resin after absorption is concentrated through ethanol elution, dry, obtains Pinoresinol diglucoside and fourth The mixed extract of face cream element diglucoside;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, aqueous solution, the glucan salt that polyethylene glycol is sequentially added into mixed solution are water-soluble Liquid adjusts pH value, stirs, and stands, after layering, takes lower layer's solution, is concentrated, and is added in ethyl alcohol and is stripped, obtains alcoholic solution 2, will Alcoholic solution 2 is concentrated, is drying to obtain general flavone;
(5) mixing of gained ursolic acid, chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside is extracted Object, general flavone, which are dissolved in ethyl alcohol, adds lecithin to get eucommia ulmoides extracts composition.
Preferably, in step (1), the mesh number of the crushing is 20-40 mesh;
Preferably, in step (1), the dosage that water is added is 5-8 times of Cortex Eucommiae quality;
Preferably, in step (1), the enzymatic hydrolysis enzyme are as follows: the mixture of cellulase and poly- methyl galacturonate enzyme;
Preferably, the mass ratio of the cellulase and poly- methyl galacturonate enzyme is 1:1-3;
Preferably, in step (2), the temperature of the cold ethyl alcohol is 1-10 DEG C;
Preferably, in step (2), the temperature of the ultrasound and filtering is no more than 10 DEG C;
Preferably, in step (2), the dosage of the ethyl alcohol is 5-8 times of 1 mass of filter residue.
Preferably, in step (4), the molecular weight of the polyethylene glycol is M=1500-3000;Preferably 2000;
Preferably, in step (4), the concentration of the Aqueous Solutions of Polyethylene Glycol is 30-40%;
Preferably, in step (4), it is total that the additional amount of the Aqueous Solutions of Polyethylene Glycol is that polyethylene glycol accounts for alcohol water mixed solution The 5-6% of quality;
Preferably, in step (4), the molecular weight of the glucan is M=40000-50000;Preferably M=45000;
Preferably, in step (4), the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline It is prepared;The glucan concentration of the glucan saline solution is 20-30%;
Preferably, in step (4), the additional amount of the glucan saline solution is that glucan accounts for the total matter of alcohol water mixed solution The 3-4% of amount;
Preferably, in step (4), the pH value is 6-7;Preferably pH value is 6;
Preferably, in step (4), the stirring carries out at 40-50 DEG C.
The object of the invention is also to provide the treatment hypertension of pregnancy eucommia ulmoides extracts compositions or the Cortex Eucommiae to mention Take application of the preparation method of compositions in preparation treatment hypertension of pregnancy drug.
Preferably, the treatment hypertension of pregnancy drug is tablet, capsule, pill, the mouth of eucommia ulmoides extracts composition Take any one of liquid or syrup.
Compared with the prior art, the technical advantages of the present invention are that:
(1) several effective components in eucommia ulmoides extracts are applied by selection in the present invention, be effectively made pregnant to treating Hypertension of being pregnent has the eucommia ulmoides extracts composition of good therapeutic effect, reduces side effect;
(2) by processes such as step by step arithmetic, purifying, by macroporous absorbent resin respectively by active ingredient chlorogenic acid, rosin The mixed extract of alcohol diglucoside and syringaresinol diglucoside prepares, and improves its purity;It again will be remaining Component sequentially adds the aqueous solution of polyethylene glycol, glucan saline solution in system, by the abstraction technique of aqueous two-phase, by it In general flavone extract, later, general flavone has been further purified after extracting;So that the impurity in entire composition subtracts It is few;Improve the purity of eucommia ulmoides extracts;
(3) in general flavone extraction process, dosage, pH value and the temperature value of polyethylene glycol and glucan have its recovery rate There is large effect, by rationally controlling each conditions, acts synergistically, preferably could effectively extract general flavone; The variation of single factors is likely to cause the variation of general flavone extraction effect, and recovery rate is made to be greatly reduced or increase flavones In impurity content;Dosage, pH value and the temperature values of the polyethylene glycol and glucan that provide in the present invention are interior can be preferably The extraction effect of general flavone is played, impurity is reduced, improves its curative effect in the hypertension of pregnancy.
(4) residual components in Cortex Eucommiae after separating-purifying can be also used for preparing other drugs, improve the medicine of Cortex Eucommiae With value, and the resource for treasuring medicinal material is saved, has reduced waste.
Specific embodiment
Embodiment 1
The eucommia ulmoides extracts composition of the hypertension of pregnancy, in parts by weight, the composition are treated in the present embodiment It include: the mixed extract 50 of 25 parts of ursolic acid, 15 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside Part, 35 parts of general flavone;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1) take Cortex Eucommiae to be crushed to 30 mesh, be added in 7 times of Cortex Eucommiae quality of water, use mass ratio be the cellulase of 1:2 with The mixture of poly- methyl galacturonate enzyme digests, and filtering obtains enzymolysis liquid and filter residue 1;
(2) filter residue 1 is taken, after petroleum ether, is placed in its 6 times 2 DEG C cold ethyl alcohol, it is ultrasonic at same temperature, Filtering, obtains alcoholic solution 1, water is added into alcoholic solution 1, the solid of precipitation is ursolic acid;
(3) enzymolysis liquid is successively adsorbed through XDA-1 type macroreticular resin, S-8 type macroporous absorbent resin;XDA-1 after absorption Type macroreticular resin is concentrated through ethanol elution, dry, obtains chlorogenic acid;
S-8 type macroporous absorbent resin after absorption is concentrated through ethanol elution, dry, obtains Pinoresinol diglucoside and fourth The mixed extract of face cream element diglucoside;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=2000) water that concentration is 35% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 6%), glucan (M= 45000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 3%), adjusts pH Value stirs at 45 DEG C to 6, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 35% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 25%;
(5) mixing of gained ursolic acid, chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside is extracted Object, general flavone, which are dissolved in ethyl alcohol, adds lecithin to get eucommia ulmoides extracts composition.
Embodiment 2
The eucommia ulmoides extracts composition of the hypertension of pregnancy, in parts by weight, the composition are treated in the present embodiment It include: the mixed extract 60 of 40 parts of ursolic acid, 10 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside Part, 30 parts of general flavone;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1) it takes Cortex Eucommiae to be crushed to 20 mesh, is added in 5 times of Cortex Eucommiae quality of water, using 1:1 cellulase and poly- methyl gala The mixture of uronic acid enzyme digests, and filtering obtains enzymolysis liquid and filter residue 1;
(2) filter residue 1 is taken, after petroleum ether, is placed in its 5 times 1 DEG C cold ethyl alcohol, it is ultrasonic at same temperature, Filtering, obtains alcoholic solution 1, water is added into alcoholic solution 1, the solid of precipitation is ursolic acid;
(3) enzymolysis liquid is successively adsorbed through XDA-1 type macroreticular resin, S-8 type macroporous absorbent resin;XDA-1 after absorption Type macroreticular resin is concentrated through ethanol elution, dry, obtains chlorogenic acid;
S-8 type macroporous absorbent resin after absorption is concentrated through ethanol elution, dry, obtains Pinoresinol diglucoside and fourth The mixed extract of face cream element diglucoside;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=1500) water that concentration is 30% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 5%), glucan (M= 40000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 4%), adjusts pH Value stirs at 40 DEG C to 7, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 30% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 20%;
(5) mixing of gained ursolic acid, chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside is extracted Object, general flavone, which are dissolved in ethyl alcohol, adds lecithin to get eucommia ulmoides extracts composition.
Embodiment 3
The eucommia ulmoides extracts composition of the hypertension of pregnancy, in parts by weight, the composition are treated in the present embodiment It include: the mixed extract 20 of 20 parts of ursolic acid, 25 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside Part, 50 parts of general flavone;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1) it takes Cortex Eucommiae to be crushed to 40 mesh, is added in 8 times of Cortex Eucommiae quality of water, using 1:3 cellulase and poly- methyl gala The mixture of uronic acid enzyme digests, and filtering obtains enzymolysis liquid and filter residue 1;
(2) filter residue 1 is taken, after petroleum ether, is placed in its 8 times 10 DEG C cold ethyl alcohol, it is ultrasonic at same temperature, Filtering, obtains alcoholic solution 1, water is added into alcoholic solution 1, the solid of precipitation is ursolic acid;
(3) enzymolysis liquid is successively adsorbed through XDA-1 type macroreticular resin, S-8 type macroporous absorbent resin;XDA-1 after absorption Type macroreticular resin is concentrated through ethanol elution, dry, obtains chlorogenic acid;
S-8 type macroporous absorbent resin after absorption is concentrated through ethanol elution, dry, obtains Pinoresinol diglucoside and fourth The mixed extract of face cream element diglucoside;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=3000) water that concentration is 40% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 6%), glucan (M= 50000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 3%), adjusts pH Value stirs at 50 DEG C to 6, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 40% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 30%;
(5) mixing of gained ursolic acid, chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside is extracted Object, general flavone, which are dissolved in ethyl alcohol, adds lecithin to get eucommia ulmoides extracts composition.
Embodiment 4
The eucommia ulmoides extracts composition of the hypertension of pregnancy, in parts by weight, the composition are treated in the present embodiment Include:
The mixing of 30 parts of ursolic acid, 20 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside is extracted 30 parts of object, 45 parts of general flavone.
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1) it takes Cortex Eucommiae to be crushed to 20 mesh, is added in 6 times of Cortex Eucommiae quality of water, using 1:2 cellulase and poly- methyl gala The mixture of uronic acid enzyme digests, and filtering obtains enzymolysis liquid and filter residue 1;
(2) filter residue 1 is taken, after petroleum ether, is placed in its 6 times 5 DEG C cold ethyl alcohol, it is ultrasonic at same temperature, Filtering, obtains alcoholic solution 1, water is added into alcoholic solution 1, the solid of precipitation is ursolic acid;
(3) enzymolysis liquid is successively adsorbed through XDA-1 type macroreticular resin, S-8 type macroporous absorbent resin;XDA-1 after absorption Type macroreticular resin is concentrated through ethanol elution, dry, obtains chlorogenic acid;
S-8 type macroporous absorbent resin after absorption is concentrated through ethanol elution, dry, obtains Pinoresinol diglucoside and fourth The mixed extract of face cream element diglucoside;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=2000) water that concentration is 30% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 5%), glucan (M= 40000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 3%), adjusts pH Value stirs at 50 DEG C to 6, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 40% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 20%;
(5) mixing of gained ursolic acid, chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside is extracted Object, general flavone, which are dissolved in ethyl alcohol, adds lecithin to get eucommia ulmoides extracts composition.
Comparative example 1
Compared with Example 1, difference is only that the composition weight number of composition is different;
The eucommia ulmoides extracts composition of the hypertension of pregnancy, in parts by weight, the composition are treated in the present embodiment It include: the mixed extract 70 of 15 parts of ursolic acid, 15 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside Part, 25 parts of general flavone;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, with embodiment 1.
Comparative example 2
Compared with Example 1, difference is only that the composition weight number of composition is different;
The eucommia ulmoides extracts composition of the hypertension of pregnancy, in parts by weight, the composition are treated in the present embodiment It include: the mixed extract 50 of 5 parts of ursolic acid, 15 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside Part, 55 parts of general flavone;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, with embodiment 1.
Comparative example 3
Compared with Example 1, difference is only that in the extraction process of effective component that pH value is different.
The eucommia ulmoides extracts composition of the hypertension of pregnancy is treated in the present embodiment, each component parts by weight are the same as embodiment 1;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1)-(3) are the same as (1)-(3) the step of embodiment 1;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=2000) water that concentration is 35% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 6%), glucan (M= 45000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 3%), adjusts pH Value stirs at 45 DEG C to 3, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 35% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 25%;
(5) with (5) the step of embodiment 1.
Comparative example 4
Compared with Example 1, difference is only that in the extraction process of effective component that pH value is different.
The eucommia ulmoides extracts composition of the hypertension of pregnancy is treated in the present embodiment, each component parts by weight are the same as embodiment 1;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1)-(3) are the same as (1)-(3) the step of embodiment 1;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=2000) water that concentration is 35% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 6%), glucan (M= 45000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 3%), adjusts pH Value stirs at 45 DEG C to 9, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 35% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 25%;
(5) with (5) the step of embodiment 1.
Comparative example 5
Compared with Example 1, difference is only that the dosage of polyethylene glycol and glucan is not in the extraction process of effective component Together.
The eucommia ulmoides extracts composition of the hypertension of pregnancy is treated in the present embodiment, each component parts by weight are the same as embodiment 1;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1)-(3) are the same as (1)-(3) the step of embodiment 1;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=2000) water that concentration is 35% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 3%), glucan (M= 45000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 6%), adjusts pH Value stirs at 45 DEG C to 6, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 35% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 25%;
(5) with (5) the step of embodiment 1.
Comparative example 6
Compared with Example 1, difference is only that the dosage of polyethylene glycol and glucan is not in the extraction process of effective component Together.
The eucommia ulmoides extracts composition of the hypertension of pregnancy is treated in the present embodiment, each component parts by weight are the same as embodiment 1;
The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy, comprising the following steps:
(1)-(3) are the same as (1)-(3) the step of embodiment 1;
(4) it will be precipitated in step (2) remaining after macroporous resin adsorption in remaining alcoholic solution and step (3) after solid Enzymolysis liquid mixing, obtains alcohol water mixed solution, and polyethylene glycol (M=2000) water that concentration is 35% is sequentially added into mixed solution Solution (Aqueous Solutions of Polyethylene Glycol is added in account for alcohol water mixed solution gross mass according to the amount of polyethylene glycol 3%), glucan (M= 45000) saline solution (glucan saline solution is added in account for alcohol water mixed solution gross mass according to glucan 3%), adjusts pH Value stirs at 45 DEG C to 6, stands, after layering, take lower layer's solution, be concentrated, it is to be taken out in 35% ethyl alcohol that mass concentration, which is added, It mentions, obtains alcoholic solution 2, it is alcoholic solution 2 is concentrated, be drying to obtain general flavone;
Wherein, the preparation method of the glucan saline solution is that glucan is dissolved in physiological saline to be prepared;Institute The glucan concentration for stating glucan saline solution is 25%;
(5) with (5) the step of embodiment 1.
Effect example
SD rat, 240-280g, SPF grade are provided by Jiangning county Qinglongshan animal reproduction field;
L-NAME (L-NAME) physiological saline solution, final concentration of 0.05g/ml;
Being suspended with 0.5%CMC-Na for embodiment 1-4 and comparative example 1-6 is dissolved, final concentration of 0.1g/ml;
Rat adaptive feeding is after a week mated female rats and male rat three days by the ratio of 2:1, with discovery Vaginal plug or introitus obviously open redness and are denoted as gestation first day, reject to the pregnant female mice that will not be pregnant for 9th day, take success The female rats of pregnancy 120 are divided into 12 groups, respectively blank control group, model group, embodiment 1-4 group and comparative example 1-6 Group, the 10th day starts to be administered, and measures the blood pressure (blood pressure is repeatedly measurement, is averaged) that preceding pregnant rat is administered, blank control Group feeding physiological saline 0.5g/kg, remaining each group inject modeling agent L-NAME according to 0.25g/kg daily, and modeling group fills wherein one The physiological saline of group stomach-filling 0.5g/kg, remaining each group are suspended according to made of 0.5g/kg stomach-filling embodiment 1-4 and comparative example 1-6 Liquid;Blood pressure after the administration of measurement in 19th day, takes blood after measurement, anaesthetize, and puts to death, and dissection takes placenta.
(1) administration front and back rat blood index variation (table 1)
The rat blood index variation of the administration of table 1 front and back (N=10)
Test group Blood viscosity (cp) Blood flow (ml/min)
Blank control group 3.81±0.62a 7.24±1.13d
Hypertension model group 5.53±0.81c 3.56±0.54f
Embodiment 1 4.12±0.72a 5.52±0.47e
Embodiment 2 4.09±1.03a 5.74±0.69e
Embodiment 3 4.21±0.55a 5.38±0.85e
Embodiment 4 4.15±0.61a 5.59±0.76e
Comparative example 1 4.73±1.23b 4.35±1.25f
Comparative example 2 4.91±0.93b 4.12±1.04f
Comparative example 3 4.67±0.77b 4.26±0.69f
Comparative example 4 4.86±1.31b 4.54±0.77f
Comparative example 5 5.13±1.28c 3.92±0.96f
Comparative example 6 5.34±0.88c 4.06±1.11f
Note: in same row, P < 0.05 between different letters;
By experimental data it is found that hypertension model group is compared with blank control group, blood viscosity is significantly raised, and blood flow is obvious It reduces, illustrates modeling success, the experiment of embodiment 1-4 is it is found that eucommia ulmoides extracts of the invention have preferably pregnant high viscosity Inhibitory effect, and blood flow can be improved;
By the experimental data of comparative example 1-6 it is found that the proportion of each effective component, the extraction process of effective component in the present invention In design parameter to the drug effect of eucommia ulmoides extracts have significant impact.
(2) influence (table 2) of the eucommia ulmoides extracts to preeclampsia rat mean arterial pressure
The rat mean arterial pressure variation of the administration of table 2 front and back (N=10)
Test group Before administration (mmHg) After administration (mmHg)
Blank control group 105.6±8.9 109.3±9.4a
Hypertension model group 103.7±10.4 142.7±3.3b
Embodiment 1 106.2±7.2 114.2±9.1a
Embodiment 2 108.1±10.1 115.3±5.2a
Embodiment 3 106.5±9.6 112.8±11.3a
Embodiment 4 107.2±5.7 113.5±6.7a
Comparative example 1 105.4±6.4 126.5±13.2c
Comparative example 2 106.9±9.2 122.3±9.4c
Comparative example 3 108.4±13.1 127.5±11.4c
Comparative example 4 107.5±8.6 123.6±7.6c
Comparative example 5 107.9±5.3 130.1±10.8c
Comparative example 6 108.6±11.5 135.5±16.4c
Note: in same row, P < 0.05 between different letters;
By experimental data it is found that before administration, rat mean arterial pressure does not have significant difference;After administration, hypertension mould For type group compared with blank control group, blood pressure is significantly raised, illustrates modeling success, and embodiment 1-4's tests Du it is found that of the invention Secondary extract has preferable inhibitory effect to the hypertension of pregnancy;
By the experimental data of comparative example 1-6 it is found that the proportion of each effective component, the extraction process of effective component in the present invention In design parameter to the drug effect of eucommia ulmoides extracts have significant impact.
Above-mentioned detailed description is illustrating for one of them possible embodiments of the present invention, the embodiment not to The scope of the patents of the invention is limited, all equivalence enforcements or change without departing from carried out by the present invention are intended to be limited solely by the technology of the present invention In the range of scheme.

Claims (10)

1. a kind of eucommia ulmoides extracts composition for treating the hypertension of pregnancy, in parts by weight, the composition includes: black bearberry The mixed extract 20-60 of 20-40 parts sour, 10-25 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside Part, 30-50 parts of general flavone.
2. the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as described in claim 1, which is characterized in that according to parts by weight Number meter, the composition includes: 25-30 parts of ursolic acid, 15-20 parts of chlorogenic acid, Pinoresinol diglucoside and syringaresinol two 35-45 parts of 30-50 parts of mixed extract, the general flavone of glucoside.
3. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as described in claim 1 or 2 is any, including Following steps:
(1) it takes Cortex Eucommiae to crush, is added to the water, digest, filtering obtains enzymolysis liquid and filter residue 1;
(2) filter residue 1 is taken, after petroleum ether, is placed in cold ethyl alcohol, ultrasound, filtering obtains alcoholic solution 1, adds into alcoholic solution 1 Enter water, the solid of precipitation is ursolic acid;
(3) enzymolysis liquid is successively adsorbed through XDA-1 type macroreticular resin, S-8 type macroporous absorbent resin;XDA-1 type after absorption is big Hole resin is concentrated through ethanol elution, dry, obtains chlorogenic acid;S-8 type macroporous absorbent resin after absorption is concentrated through ethanol elution, It is dry, obtain the mixed extract of Pinoresinol diglucoside and syringaresinol diglucoside;
(4) through macroporous resin adsorption after remaining enzymatic hydrolysis will be precipitated after solid in remaining alcoholic solution and step (3) in step (2) Liquid mixing, obtains alcohol water mixed solution, aqueous solution, the glucan saline solution of polyethylene glycol is sequentially added into mixed solution, adjusts PH value is saved, is stirred, stands, after layering, takes lower layer's solution, is concentrated, is added in ethyl alcohol and is stripped, alcoholic solution 2 is obtained, by alcoholic solution It is 2 concentrated, be drying to obtain general flavone;
(5) by the mixed extract of gained ursolic acid, chlorogenic acid, Pinoresinol diglucoside and syringaresinol diglucoside, General flavone, which is dissolved in ethyl alcohol, adds lecithin to get eucommia ulmoides extracts composition.
4. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as claimed in claim 3, which is characterized in that In step (1), the mesh number of the crushing is 20-40 mesh;The dosage that water is added is 5-8 times of Cortex Eucommiae quality.
5. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as claimed in claim 3, which is characterized in that In step (1), the enzymatic hydrolysis enzyme are as follows: the mixture of cellulase and poly- methyl galacturonate enzyme;The cellulase and The mass ratio of poly- methyl galacturonate enzyme is 1:1-3.
6. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as claimed in claim 3, which is characterized in that In step (2), the temperature of the cold ethyl alcohol is 1-10 DEG C;The ultrasound and the temperature of filtering are no more than 10 DEG C.
7. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as claimed in claim 3, which is characterized in that In step (2), the dosage of the ethyl alcohol is 5-8 times of 1 mass of filter residue.
8. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as claimed in claim 3, which is characterized in that In step (4), the molecular weight of the polyethylene glycol is M=1500-3000;The additional amount of the Aqueous Solutions of Polyethylene Glycol is poly- second Glycol accounts for the 5-6% of alcohol water mixed solution gross mass;
The molecular weight of the glucan is M=40000-50000;The additional amount of the glucan saline solution is that glucan accounts for alcohol The 3-4% of water mixed solution gross mass.
9. the preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy as claimed in claim 3, which is characterized in that In step (4), the pH value is 6-7;The stirring carries out at 40-50 DEG C.
10. the eucommia ulmoides extracts composition or the claim 3-9 that treat the hypertension of pregnancy as described in claim 1-2 is any are any The preparation method of the eucommia ulmoides extracts composition of the treatment hypertension of pregnancy answering in preparation treatment hypertension of pregnancy drug With.
CN201910896111.8A 2019-09-22 2019-09-22 Eucommia ulmoides extract composition for treating gestational hypertension and application thereof Active CN110496148B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910896111.8A CN110496148B (en) 2019-09-22 2019-09-22 Eucommia ulmoides extract composition for treating gestational hypertension and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910896111.8A CN110496148B (en) 2019-09-22 2019-09-22 Eucommia ulmoides extract composition for treating gestational hypertension and application thereof

Publications (2)

Publication Number Publication Date
CN110496148A true CN110496148A (en) 2019-11-26
CN110496148B CN110496148B (en) 2021-04-30

Family

ID=68592396

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910896111.8A Active CN110496148B (en) 2019-09-22 2019-09-22 Eucommia ulmoides extract composition for treating gestational hypertension and application thereof

Country Status (1)

Country Link
CN (1) CN110496148B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113413392A (en) * 2021-07-07 2021-09-21 江西普正制药股份有限公司 Eucommia ulmoides extract composition and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
彭红梅等: "杜仲颗粒结合常规疗法治疗妊娠期高血压疾病的临床疗效", 《重庆医学》 *
彭胜等: "双水相体系萃取分离杜仲黄酮", 《中药材》 *
杜仲综合利用技术国家地方联合工程实验室: "杜仲的化学成分与功能", 《HTTPS://DUZHONG.JSU.EDU.CN/INFO/1017/1169.HTM》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113413392A (en) * 2021-07-07 2021-09-21 江西普正制药股份有限公司 Eucommia ulmoides extract composition and preparation method and application thereof

Also Published As

Publication number Publication date
CN110496148B (en) 2021-04-30

Similar Documents

Publication Publication Date Title
CN100534474C (en) Medicine composition for enhancing immunity, and its preparation method and use
CN101428086B (en) Traditional Chinese medicine preparation for treating peptic ulcer and preparation method thereof
CN102205107B (en) Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof
CN109646471A (en) A kind of activation notoginsenoside rich in rare ginsenoside is in the application prepared in oral care product
CN110496148A (en) A kind of eucommia ulmoides extracts composition that treating the hypertension of pregnancy and its application
CN103341074A (en) Application of Yixuanning granules in preparation of medicaments for treating insomnia
CN104337927A (en) Calyx seu fructus physalis extractive, medicine composition and/or functional food
CN102784230B (en) Pharmaceutical composition preparation for treating nutritional anemia
CN105012770A (en) Health drink and preparation method thereof
CN108902989A (en) A kind of auxiliary improves the ginseng peptide and preparation method thereof of cardiovascular and cerebrovascular disease
CN100500174C (en) Medicine composition used for lowering blood-sugar, preparation method and use thereof
CN105055851A (en) Chinese medicinal composition for treatment of diabetes, preparation and application thereof
CN114468291A (en) Inositol composition for improving female infertility and preparation method thereof
CN110623993A (en) Compound nutritional tablet of traditional Chinese medicine composition for treating gynecological inflammation and preparation method thereof
CN107468849A (en) A kind of medicine for treating chronic renal failure and preparation method thereof
CN108721353A (en) A kind of preparation method of Radix Notoginseng oral solution
CN107811907A (en) A kind of body lotion for promoting subcutaneous fat to decompose
CN116942771B (en) Traditional Chinese medicine composition for treating coronary heart disease and application thereof
CN113521186B (en) Hypoglycemic drug and preparation method and application thereof
CN102579801B (en) Traditional Chinese medicine preparation for treating diabetic syndrome and preparation method of same
CN107137456A (en) It is a kind of to treat medicine of chronic osteomyelitis and its preparation method and application
CN101040977B (en) Medicine for treating prostate disease and method for preparing same
CN104225014B (en) A kind of Tibetan medicine for the treatment of diabetes
CN105168430A (en) Medicine composition for preventing and treating gout and preparation method thereof
CN105250919B (en) It is a kind of for preventing and/or the Chinese medicine composition for treating liver disease and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant